Artificial Intelligence

As AI creates data bottlenecks, Lumen launches a new Multi-Cloud Gateway and metro network expansion, aiming to simplify hybrid IT and power innovation.

A new series from A3 and BBC StoryWorks moves beyond efficiency to show how automation is augmenting human lives in healthcare, education, and more.

Landmark study in JAMA Neurology shows BRIUMVI offers near-zero relapse rates and stable disability, reshaping long-term multiple sclerosis treatment.

SaaS veteran Alison Forsythe takes the helm at Intellinetics, tasked with turning heavy investment into profitable growth in the booming digital transformation market.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

Vexcel announces its 2026 plan to capture 5.2M km² of U.S. aerial imagery, powering critical industries from insurance to AI with unprecedented detail.

A new program in Michigan uses AI to analyze existing CT scans, detecting silent heart risks and connecting patients to care before symptoms even appear.

A new five-year deal will leverage patient-derived stem cells and AI to revolutionize the hunt for Alzheimer's cures, aiming to bridge a critical gap.

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

As it celebrates 50 years, SpringGreen is leveraging advanced AI partnerships to redefine lawn care, empowering franchisees and enhancing service.

New research reveals a swift move to AI in accounting, but professionals insist on one condition: technology will assist, not replace, human oversight.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.

With a new regulatory chief, Ray Therapeutics accelerates its mission to bring its goggle-free optogenetic therapies for blindness through clinical trials.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

An Indiana firm's implantable pump gains key FDA status, promising a future with less mental burden for Type 1 Diabetes patients. But the road is long.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

Agricultural supplier Farmmi Inc. stuns with a new AI marketing unit, Bluesage, that signed a global client in just two weeks. Is this the future?

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.